Clinical trial
Protocol for ROTATEQ™ Post-Marketing Surveillance
NCT01357174 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protocol for ROTATEQ™ Post-Marketing Surveillance
- Lead sponsor
- Merck Sharp & Dohme LLC
- Phase
- Observational
- Overall status
- Terminated
- Start date
- October 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 915 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.